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Abstract 
Adverse Drug Reactions (ADRs) are the 4th cause of death in hospitalized 
patients. Despite the importance of clinical trials, they have many limitations 
mainly based on time and population. Therefore, other ways of spotting ADRs had 
to be created, as for instance, the healthcare professionals reporting systems and 
the spontaneous patients reporting systems created by the FDA or the EMA. 
Nevertheless, it has been proven that the results obtained are not yet as 
satisfactory as expected. 
Health-related social media can be used along with these reporting 
systems in order to obtain possible information from a source where patients feel 
more comfortable sharing their experiences by exchanging information. 
Therefore, the creation of the first corpus annotated with drugs and 
adverse events from social media in Spanish in order to train and evaluate 
machine-learning techniques is one of the main goals throughout this project. 
Furthermore, the implementation of a dictionary-based approach to detect 
mentions and to be tested with this gold-standard is the other main goal in this 
investigation. 
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1. Introduction 
1.1. Motivation 
It is well-known that adverse drug reactions (ADRs) are an important 
health problem. Actually, ADRs are the 4th cause of death in hospitalized patients 
(Wester et al., 2008 [35]). Thus, the field of pharmacovigilance is currently 
receiving a great attention due to the high and growing importance of drug safety 
incidents (Bond and Raehl, 2006 [7]) as well as to their high associated costs (van 
Der Hooft et al., 2006 [29]). 
Since many ADRs are not captured during clinical trials, the major 
medicine regulatory agencies such as the US Food and Drug Administration (FDA) 
or the European Medicines Agency (EMA) require healthcare professionals to 
report all suspected adverse drug reactions. However, studies show that ADRs are 
under-estimated due to the fact that they are reported by voluntary reporting 
systems (Bates et al., 2003 [4]; van Der Hooft et al., 2006 [29]; McClellan, 2007 
[23]). In fact, it is estimated that only between 2 and 10 per cent of ADRs are 
reported (Rawlins, 1995 [31]). Healthcare professionals must perform many tasks 
during their workdays and thus finding the time to use these surveillance 
reporting systems is very difficult. Furthermore, healthcare professionals tend to 
report only those ADRs on which they have absolute certainty of their existence. 
Several medicines agencies have implemented spontaneous patient reporting 
systems in order for patients to report ADRs themselves. Some of these systems 
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are the MedWatch from the FDA, the Yellow Cards from the UK Medicines agency 
(MHRA) or the website1 developed by the Spanish Agency of Medicines and 
Medical devices (AEMPS). Unlike reports from healthcare professionals, patient 
reports often provide more detailed and explicit information about ADRs 
(Herxheimer et al., 2010 [15]). Another important contribution of spontaneous 
patient reporting systems is to achieve patients having a more central role in their 
treatments. However, despite the fact that these systems are well-established, 
the rate of spontaneous patient reporting is very low probably because many 
patients are still unaware of their existence and even may feel embarrassed when 
describing their symptoms.  
In this study, our hypothesis is that health-related social media can be 
used as a complementary data source to spontaneous reporting systems in order 
to detect unknown ADRs and thereby to increase drug safety. In recent days, 
social media on health information, just like has happened in other areas, have 
seen a tremendous growth (Hill et al., 2013 [16]). Examples of social media sites 
include blogs, online forums, social networking, and wikis, among many others. In 
this work, we focus on health forums where patients often exchange information 
about their personal medical experiences with other patients who suffer the same 
illness or receive similar treatment. Some patients may feel more comfortable 
sharing their medical experiences with each other rather than with their 
healthcare professionals. These forums contain a large number of comments 
describing patient experiences that would be a fertile source of data to detect 
unknown ADRs. 
Although there have been several research efforts devoted to developing 
systems for extracting ADRs from social media, all studies have focused on social 
media in English, and none of them have addressed the extraction from Spanish 
social media. Moreover, the problem is that these studies have not been 
compared with each other, and hence it is very difficult to determine the current 
“state-of-art” of the techniques for ADRs extraction from social media. This 
comparison has not been performed due to the lack of a gold-standard corpus for 
ADRs.  
                                                          
1
 https://www.notificaram.es/  
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We hope our system will be beneficial to AEMPS as well as to the 
pharmaceutical industry in the improvement of their pharmacovigilance systems. 
1.2. Objectives 
Following with the motivation of this study, the main goal of our work is 
twofold: On the one hand, to create a gold-standard corpus annotated with drugs 
and adverse events and on the other hand, to develop a system to automatically 
extract mentions of drugs and adverse events from Spanish health-related social 
media sites. The corpus is formed by patients’ comments from Forumclinic2, a 
health online networking website in Spanish. This is the first corpus of patient 
comments annotated with drugs and adverse events in Spanish. Also, we believe 
that this corpus will facilitate comparison for future ADRs detection from Spanish 
social media.  
This work has been performed in “TrendMiner: Large-scale Cross-lingual 
Trend Mining of Real-time media streams” project (FP7-ICT 287863), 
http://www.trendminer-project.eu/. LaBDA Research Group participates in this 
project. The goal of TrendMiner is to deliver innovative, portable open-source 
real-time methods for cross-lingual mining and summarisation of large-scale 
stream media. TrendMiner will achieve this through an inter-disciplinary 
approach, combining deep linguistic methods from text processing, knowledge-
based reasoning from web science, machine learning, economics, and political 
science. Results will be validated in three high-profile case studies: financial 
decision support (with analysts, traders, regulators, and economists), political 
analysis and monitoring (with politicians, economists, and political journalists) and 
heatlh domain. The techniques will be generic with many business applications: 
business intelligence, customer relations management, community support. The 
project will also benefit society and ordinary citizens by enabling enhanced access 
to government data archives, summarisation of online health information, and 
tracking of hot societal issues. 
                                                          
2
 http://www.forumclinic.org  
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1.2.1. Specific objectives 
Below the specific objectives are shown: 
 Create a technological study regarding the main developed systems to 
date which detect ADRs from social media. 
 Carry out a study of the main health-based social media. 
 Analyze the main terminological resources regarding drugs and ADRs in 
Spanish language. 
 Study and analyze Textalytics, a multilingual tool intended for text 
analysis. 
 Study and analyze the text analysis platform, GATE. 
 Create a corpus annotated with drugs and adverse events which will be 
later used in order to develop and evaluate our extraction system. 
 Calculate the inter-annotator agreement for the corpus. This metric will 
give us a clue on the degree of difficulty that the annotation task carries, 
and on the quality of the corpus’ annotation. 
 Build a dictionary for drugs and adverse events based on the 
aforementioned resources. 
 Implement a system for the detection of drugs and adverse events by 
means of a dictionary-based approach. 
 Evaluate our system with the corpus previously created. 
 Conduct an error analysis in order to obtain the main causes of false 
positives and false negatives in our system. 
 Analyze all possible approaches for future work which are intended to 
solve the errors detected in the past.  
1.3. Roadmap 
A brief overall view of the contents included in the document is next 
explained: 
 Chapter 1 ‘Introduction’: The brief introduction to the project, starting 
with the motivations which made us develop this project, continuing with 
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all the objectives to be covered and to ending up with an overview of the 
content in each chapter of the document. 
 Chapter 2 ‘Background’: The review of the social media analysis which 
took place at first, along with the analysis of the terminological resources 
both for drugs and adverse events, all of them in Spanish. Furthermore, 
the related work is included. 
 Chapter 3 ‘The SpanishADRs corpus’: The whole process which brought to 
life the first Spanish corpus annotated with drugs and adverse events. 
From its creation and annotation to the results which showed up. 
 Chapter 4 ‘System description’: The architecture and explanation of the 
dictionary-based approach that we implemented in order to extract drugs 
and adverse events from user comments from Spanish social media. 
 Chapter 5 ‘Evaluation’: The introduction to the way in which the system 
was evaluated, followed by the results obtained. The main focus is on the 
error analysis.  
 Chapter 6 ‘Budget’. The planning and total budget of the project, including 
all the tasks related to the project, as well as the direct and indirect 
expenses. 
 Chapter 7 ‘Conclusions and future work’. The learnings obtained 
throughout the realization of this project, as well as the future work which 
should be carried on in order to improve the performance. 
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2. Background 
2.1. Information extraction applied to 
biomedical domain 
The main investigation area in which to place this project is the Natural 
Language Processing (NLP). NLP manages ways to translate between computer 
and human languages, being its main objective to automate this translation 
process. 
One step further, we focus on Information Extraction (IE), were we deal 
with automatically extracting structured information from unstructured machine-
readable documents (in this case, social media). Basically, this task is based in 
processing human language texts by virtue of the aforementioned natural 
language processing. 
The main motivation for these two fields came from competitions 
regarding recognition of named entities, such as people names or organizations 
from news articles. 
This fact leads us to the next stop in our investigation: Named-Entity 
Recognition (NER). As we can figure out from the text above, NER is a sub-duty of 
the information extraction, with the goal of locating and classifying elements in a 
text into pre-defined categories.  
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Entities are generally noun phrases, normally of one to a few tokens 
length, which are found in unstructured text. The most common form of entity is 
the named entity (names of people, locations and companies). Nevertheless, 
nowadays the term entities has been expanded until including generics such as 
disease names, protein names, paper titles or journal names. 
As a matter of fact, this investigation is based on the biomedical domain. 
More in concrete, in the Biomedical Named Entity Recognition (BNER), defined as 
the task of recognizing and categorizing entity names in biomedical domain. To 
date, most of the studies of BNER focused on genes and proteins, leaving the drug 
names more unattended. Some of the difficulties regarding BNER are: 
 Drug names can be expressed not only by its name, but also with plurals, 
compounds and anaphoric expressions. 
 Due to the fast changes in vocabulary, new drugs are constantly created, 
and older ones can be renamed. This makes it essential to have updated 
resources. 
 Drug names are synonymous with other drug names.  
 Acronyms and abbreviations are widely used in biomedical texts. 
Focusing in this project, we will apply BNER techniques to recognize both 
drugs and adverse events from heath related social media, in Spanish language. 
2.2. Review of the main social media in 
Spanish language 
The first step towards the realization of this project was the decision of 
which social media was going to be used. In the first place, a large number of 
options were on top of the table (Twitter3, Facebook4, Tuenti5, blogs, forums...), 
always under the condition of obtaining the contents in Spanish.  
                                                          
3
 http://twitter.com 
4
 http://facebook.com 
5
 http://tuenti.com 
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A detailed analysis of each and every of the options was then done 
separately in order to be able to decide the most appropriate media for the 
project's context, pharmacovigilance.  
Finally, the decision of the social media from which to obtain the corpus 
to be used in the project was done. 
Twitter 
From the beginning Twitter was the first and most attractive option. The 
interest towards this social media is growing exponentially, as so is happening 
with the studies based on it. Companies are increasingly using it in order to detect 
market traces, understand their corporative reputation... 
Twitter data speaks for itself, with one million new accounts created every 
day (11 per second), more than 300.000 daily visits and a total of approximately 
500 million users (from which 140 million are active users). 
Every second 750 tweets are sent in average, with a total of 175 million on 
a busy day. Another piece of relevant data is the number of searches done every 
month in Twitter, with a number of 24.000 million (against the 13.500 million 
combined between Yahoo! and Bing). 
Never mind, on the other hand Twitter has also negative aspects. Firstly, 
regarding tweets, Twitter only allows access to 7 days of comments at one point 
in time. Therefore, the best option would be buying collections of tweets, which 
are available, and work with them. 
Moreover, regarding pharmacovigilance, Graciela et al. (2013) [12] 
gathered tweets for one month, obtaining 42.327 of them which had a 
relationship to their set of drugs and diseases. From those, around half of them 
were advertisements, and from the useful ones (the rest of them), a small 
percentage was annotated and worked with. Only a 6.5% of this set included an 
adverse reaction. More specifically, removing the ones related to the term 
"nicotine", they had only between 1 - 2% left. 
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 COUNT 
Total Twitter Data collected 42327 
Tweets that are not advertisements 22739 
Tweets manually annotated 3338 
Tweets containing an adverse reaction 216 
Table 1: Summary of retrieved tweets by Dr. Graciela González 
Taking these results into account, and understanding that there is a very 
relevant additional handicap which is the language (Spanish), Twitter would have 
to be a discarded option to be the chosen social media for the corpus of this 
project.  
Figure 1: Example of a tweet with an adverse event 
Facebook 
To this day, Facebook owes many more users than Twitter, being this 
number of around 1.250 million in total. Its main drawback when it comes to 
using this social media for this corpus is the fact that Facebook does not have such 
a well-defined timeline as Twitter, which makes the information extraction way 
more complicated. 
On the other hand, the existence of Facebook Groups is really interesting, 
where users can exchange posts and messages related to a certain topic (for 
instance, related to a disease or drug, which would be useful for the corpus). 
Despite this, the access to these groups tends to be restricted to members, and 
the information in Spanish continues being limited in the context of 
pharmacovigilance. Therefore, Facebook is another discarded option. 
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Figure 2: Example of a Facebook comment with an adverse event 
Blogs and Forums 
Forums (with a 28% of active users) are the fourth most used social media 
in Spain (right after Facebook, YouTube6 and Twitter). Blogs are just a few steps 
from forums, with a 17% of active users, as shown by The Cocktail Analysis7. The 
dynamic use of this couple of medias makes extracting information from them 
interesting enough. 
A blog is a website which is periodically updated, and that contains texts 
or articles from one or several authors, being the owner the one who has the last 
word about what is then published under it. 
Furthermore, a forum is a place for opinion and experience exchange, 
where everyone can write, creating new topics or adding some value to the 
existing ones. 
Taking these two options into account, the higher dynamism and greater 
participation which characterizes forums makes them a more attractive choice for 
the project's context. Moreover, the existence of forums of all types and domain 
makes it easy to search for those which are related to the pharmacovigilance 
context.  
In conclusion, due to all these advantages, forums are chosen as the social 
media to create the corpus. Among the forums of interest, the most important 
ones are: 
                                                          
6
 http://youtube.com 
7
 http://tcanalysis.com/ 
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 Forumclínic 
 PortalesMédicos8  
 EnFemenino9  
 Saluspot10 
Figure 3: Example of a forum post with an adverse event 
Forum election 
Once the decision was made to use forums as social media, an analysis of 
some of the options had to be done. 
All forums follow the same structure. First, the creation of a main 
category (for instance, schizophrenia - esquizofrenia), under which people start 
new topics with the questions/comments/experiences they want to expose (for 
example, the adverse effects of a drug). Among these, people registered in those 
webs (or accessing as invited) leave their own comments, experiences, doubts, 
questions or answers, always related to the topic under which they are writing.  
This makes it possible to obtain different experiences and points of view 
of a same topic. Regarding the project's context, this is something really positive 
when it comes to a medical or pharmaceutical issue.  
The three aforementioned forums are quite similar between them, and 
therefore comments from all of them could be valid. Despite this, it has been 
decided to focus on one of them in particular. The chosen one has been 
Forumclinic, which will be deeply explained in section 3.1. 
                                                          
8
 http://www.portalesmedicos.com 
9
 http://www.enfemenino.com 
10
 https://www.saluspot.com/conocenos/quienes-somos-saluspot 
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2.3. Review of the main terminological 
resources for drugs and adverse events 
in Spanish language 
Drug resources 
The project required a complete, trustworthy and manageable drug 
resource. There are several of them on the Internet, with different levels of access 
difficulty. 
The main barrier is, once again, the language, as the Spanish names of the 
drugs were needed. This means that some of the resources are directly discarded. 
After filtering, there were four main candidates: 
 Snomed CT11 
 Nomenclátor Digitalis - Integra12 
 AEMPS's CIMA13 
 Vademecum14 
 
Snomed CT 
Snomed CT (Systematized Nomenclature of Medicine – Clinical Terms) is a 
terminology whose content consists of concepts, descriptions and relationships, 
and has as a goal representing in a precise way their information and clinic 
knowledge. 
It is owned, maintained and distributed by the International Health 
Terminology Standards Development Organisation15 (IHTSDO), of which Spain is a 
member, making it accessible in Spanish.  
                                                          
11
 http://www.nlm.nih.gov/research/umls/licensedcontent/snomedctfiles.html 
12
 http://www.msssi.gob.es/profesionales/farmacia/nomenclatorDI.htm 
13
 http://agemed.es/cima/pestanias.do?metodo=accesoAplicacion 
14
 http://www.vademecum.es 
15
 http://www.ihtsdo.org/ 
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In 2011, it included over 311.000 concepts with meaning and definition, 
organized into acyclic taxonomic hierarchies, and linked by around 1.360.000 links 
(the aforementioned relationships). 
The Spanish Edition of the International Release is updated each year in 
April and October, which means that the last accessible version is the first one of 
2013.  
Once registered in the UMLS Terminology Services (UTS) in order to 
access the UMLS resources, a procedure which can take up to three days, you get 
access to the relational database which is organized in "concepts", "descriptions" 
and "relationships". 
CONCEPTID FULLYSPECIFIEDNAME SNOMEDID ISPRIMITIVE 
329652003 Ibuprofen 200mg tablet (product) C-50294 1 
329653008 Ibuprofen 400mg tablet (product) C-50295 1 
329654002 Ibuprofen 600mg tablet (product) C-50296 1 
Table 2: Example of the drug "Ibuprofen(o)" in the Snomed CT’s contents file 
Despite having the Spanish translation in the aforementioned version, 
part of the contents are still in English, which does not suit the needs. Specifically, 
they are the drug names which are not translated, but have the English name (in 
the "concepts" file). Therefore, when searching for "Ibuprofeno", for instance, no 
result is achieved, as in the database it is shown as "Ibuprofen". 
Due to this problem, this resource was discarded. 
Nomenclátor Digitalis - Integra 
Nomenclátor Digitalis-Integra is maintained, updated and distributed by 
the Spanish Ministry of Health (Ministerio de Sanidad, Servicios Sociales e 
Igualdad16), and therefore has national scope.  
On the one hand, Nomenclátor Digitalis is a list containing relations 
between pharmaceutical products with its product identification, price and 
                                                          
16
 http://www.msssi.gob.es/ 
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contribution to the user, used for medical prescriptions invoicing. On the other 
hand, Integra is a complementary file which contains different types of 
pharmaceutical products classified following the ATC system and including 
information about their content identification, DDD and administrative 
characteristics.  
It contains 47.700 data entries (it includes the Digitalis DB resource), and 
it had its last update on March 2012.  
It has a downloadable version (both in .txt and .mdb), with no need to 
register a website.   
CODIGO NOMBRE NOMBRE2 CODATC CAGR CODDOE CODDOH 
984690 IBUPROFENO ROVI 500MG M01AE01 0 P14793 H13375 
Table 3: Part of an entry of the Integra document 
Other resources were studied in case they gave a better performance. 
AEMPS's CIMA 
CIMA is a resource provided and maintained by The Spanish Agency for 
Medications and Healthcare Products (AEMPS17 - Agencia Española de 
Medicamentos y Productos Sanitarios). It is an application which includes all 
authorized drugs in Spain. Its goal is to provide all information about each and all 
of them, and it allows the access to the drug's data sheet, as well as its patient 
information leaflet. 
The drug's data sheet is a document which includes the drug's description, 
indications, dosage, precautions and counter-indications, adverse reactions, 
pharmaceutical information and properties. 
The patient information leaflet is the document included inside the box of 
the medicine, and whose goal is to inform the patient. 
The application encloses the following information related to the 
authorized drugs in Spain: 
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 Drug's name 
 Generic ingredient(s)'s name 
 Marketing authorization holder's name 
 National code 
 Register number 
 Authorization date 
 Presentation name 
 Presentation status (authorized / temporarily suspended / revoked) 
 Availability in market 
 Need and type of medical prescription 
 Drug's data sheet 
 Drug's package leaflet 
All authorized drugs in Spain are codified, including the National Code, 
Fabrication Laboratory, Commercialization Laboratory, ATC Code or Generic 
Ingredient among other relevant information. 
CIMA is a downloadable tool which consists in a relational database in xml 
format. In total, there are 15 documents, 14 of them including different and 
relevant information (see below) such as ATC codes, laboratories, or generic 
ingredients, and a main file (Prescripcion.xml), with the prescription of all the 
available drugs, including the information of the rest of the documents, codified in 
a proper and defined way. 
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Figure 4: Example of an entry from Prescripción 
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Figure 5: Example of an entry from DICCIONARIO_ATC 
Figure 6: Example of two entries from DICCIONARIO_PRINCIPIOS_ACTIVOS 
Figure 7: Example of an entry from DICCIONARIO_LABORATORIOS 
Among all files, the following information can be obtained: 
CONTENT NUMBER FILE 
Drugs 16418 Prescripcion.xml 
Generic ingredients 2228 DICCIONARIO_PRINCIPIOS_ACTIVOS.xml 
ATC codes 1795 DICCIONARIO_ATC.xml 
Laboratories 847 DICCIONARIO_LABORATORIOS.xml 
 
Table 4: Summary of CIMA's content 
Due to the high amount of information and the clarity of the content, 
CIMA was chosen as one of the two resources for drugs. 
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Vademecum 
Vademecum is a guide of pharmaceutical products which is published and 
updated periodically, containing information provided by pharmaceutical 
companies.  
In its online version, drugs, generic ingredients, laboratories, diseases, 
international equivalences of drugs, and drug interactions can be searched for.  
Regarding drugs (over 18.200 drugs), they can be searched by name, 
clinical pharmacology, disease and symptoms, generic ingredient or laboratory. 
Generic ingredients can be accessed by name, clinical pharmacology and marketer 
laboratory.  
Vademecum is the reference pharmacological guide in Spain, manageable 
and trustworthy, and therefore it was chosen to be part of the drug resource. 
Adverse Event Resources 
A total of 12 resources were analysed in order to come up with the best 
possible resource for adverse events. The 6 most important ones are: 
 BOT Plus18 
 MedLine Plus19 
 Vademecum20 
 MedDRA21 
BOT Plus 
The Health Knowledge Data Base, BOT Plus (Base de Datos del 
Conocimiento Sanitario, BOT Plus) is a computer program developed by the 
General Council of the Oficial Pharmaceutical Schools (Consejo General de 
Colegios Oficiales de Farmacéuticos) for the consult of homogeneous and updated 
information relative to drugs, health products, diseases and interactions. 
                                                          
18
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 http://www.nml.nih.gov/medlineplus/spanish/druginfo/meds/a681006-es.html 
20
 http://www.vademecum.es/medicamentos-a_1 
21
 http://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/MDRSPA/termtypes.html 
Chapter 2: Background 
 
27 
 
All the information regarding drugs and health products commercialized 
in Spain is retrieved from main official sources, such as AEMPS (Agencia Española 
de Medicamentos y Productor Sanitarios), EMEA22 (European Medicines Agency) 
or pharmaceutical laboratories among others. 
It contains all the updated information related to over 20.000 drugs and 
more than 2.000 generic ingredients commercialized in Spain. 
Nevertheless, the difficult access to the resource makes it less attractive. 
MedlinePlus 
MedlinePlus is the National Institutes of Health's (NIH23) website intended 
for patients. The National Library of Medicine24, which is part of the NIH, created 
and maintains MedlinePlus to give users authoritative up-to-date health 
information, such as diseases, conditions and wellness issues in a patient-oriented 
language.  
It includes more than 900 health topics both in Spanish and in English, 
with information from over 1.000 organizations and more than 35.000 links to 
health information links. 
Drugs and supplements can be browsed by generic or brand name, 
obtaining their information leaflets. Within the leaflet, a section for side effects of 
the medication is included, achieving known adverse effects of the drug in a 
patient-oriented language. 
Again, the difficult access to the information makes the resource not 
interesting. 
MedDRA 
MedDRA (Medical Dictionary for Regulatory Activities) was developed by 
the International Conference on Harmonization of Technical Requirements for 
Registration of Pharmaceuticals for Human Use (ICH25) in the late 1990s. This 
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 http://www.nih.gov/ 
24
 http://www.nlm.nih.gov/ 
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medical terminology dictionary is clinically validated and used by the regulatory 
authorities in the pharmaceutical industry during the regulatory process.  
The ICH MedDRA Management Board is the responsible for the direction 
of MedDRA, and is in charge of overseeing all the activities of the ICH MedDRA 
Maintenance and Support Services Organization (MSSO26), tasked to maintain, 
develop and distribute MedDRA. 
MedDRA is a multilingual terminology allowing most users to operate in 
their native languages, as it has been translated and is maintained in the following 
languages: Chinese, Czech, Dutch, French, German, Hungarian, Italian, Japanese, 
Portuguese and Spanish. Thus, every term in MedDRA has an associated 8-digit 
code which is the same in all languages. 
MedDRA has a very logical and well organised structure. It is composed of 
a five levels hierarchy, which goes from more very general to very specific. At the 
most specific level, called "Lowest Level Terms" (LLTs), there are 72072 terms 
which parallel how information is communicated. These LLTs reflect how an 
observation can be reported in practice.  
On the next level, "Preferred Terms" (PTs) (20307 different ones), each 
member is a single medical concept for a symptom, sign, disease diagnosis, 
therapeutic indication, investigation, surgical or medical procedure, and medical 
social or family history characteristic. Each LLT is linked to only one PT. Each PT 
has at least one LLT itself. 
The "High Level Terms" (HLTs) group related PTs based on anatomy, 
pathology, physiology, etiology or function. In the same way, "High Level Group 
Terms" (HLGTs) groups HLTs. 
The most general group, "System Organ Classes" (SOCs), group the HLGTs. 
They are groupings by etiology, manifestation site or purpose. 
MedDRA is the adverse event classification dictionary approved by the 
ICH, and therefore a very reliable resource for the adverse events, thus it was 
chosen as one of the two resources for drugs. 
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Vademecum 
This resource has been previously described as a drug resource.  
Within the drug's information, the patient information leaflet is generally 
accessible. One of its paragraphs is dedicated to known adverse effects of the 
drug, written in a patient-oriented language.  
This information is a valid support for the resource, more significantly 
taking into account that Vademecum was also chosen as a drug resource. 
2.4. State of the art of drug-effect 
recognition in Social Media 
In recent years, the application of Natural Language Processing (NLP) 
techniques to mine adverse reactions from texts has been explored with 
promising results, mainly in the context of drug labels (Gurulingappa et al., 2013 
[14]; Li et al., 2013 [22]; Kuhn et al., 2010 [19]), biomedical literature (Xu and 
Wang, 2013 [34]), medical case reports (Gurulingappa et al., 2012 [13]) and health 
records (Friedman, 2009 [11]; Sohn et al., 2011 [32]). However, as it will be 
described below, the extraction of adverse reactions from social media has 
received much less attention. 
In general, medical literature, such as scientific publications and drug 
labels, contains few grammatical and spelling mistakes. Another important 
advantage is that this type of texts can be easily linked to biomedical ontologies. 
Similarly, clinical records present specific medical terminology and can also be 
mapped to biomedical ontologies and resources. Meanwhile social media texts 
are markedly different from clinical records and scientific articles, and thereby the 
processing of social media texts poses additional challenges such as the 
management of meta-information included in the text (for example as tags in 
tweets) (Bouillot et al., 2013 [10]), the detection of typos and unconventional 
spelling, word shortenings (Neunedert et al, 2013 [25]; Moreira et al., 2013 [24]) 
and slang and emoticons (Balahur, 2013 [3]), among others. Moreover, these 
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texts are often very short and with an informal nature, making the processing task 
extremely challenging. 
Regarding the identification of drug names in text, during the last four 
years there has been significant research efforts directed to encourage the 
development of systems for detecting these entities. Concretely, shared tasks 
such as DDIExtraction 2013 (Segura-Bedmar et al., 2013 [27]), CHEMDNER 2013 
(Krallinger et al., 2013 [18]) or the i2b2 Medication Extraction challenge (Uzuner 
et al., 2010 [33]) have been held for the advancement of the state of the art in 
this problem. However, most of the work on recognizing drugs concerns either 
biomedical literature (for example, MedLine articles) or clinical records, thus 
leaving unexplored this task in social media streams.  
Leaman et al., (2010) [20] developed a system to automatically recognize 
adverse effects in user comments. A corpus of 3,600 comments from the 
DailyStrength health-related social network was collected and manually 
annotated with a total of 1,866 drug conditions, including beneficial effects, 
adverse effects, indications and others. To identify the adverse effects in the user 
comments, a lexicon was compiled from the following resources: (1) the COSTART 
vocabulary (National Library of Medicine, 2008), (2) the SIDER database (Kuhn et 
al., 2010 [19]), (3) MedEffect27 and (4) a list of colloquial phrases which were 
manually collected from the DailyStrength comments. The final lexicon consisted 
of 4,201 concepts (terms with the same CUI were grouped in the same concept). 
Finally, the terms in the lexicon were mapped against user comments to identify 
the adverse effects. In order to distinguish adverse effects from the other drug 
conditions (beneficial effects, indications and others), the systems used a list of 
verbs denoting indications (for example, help, work, prescribe). Drug name 
recognition was not necessary because the evaluation focused only on a set of 
four drugs: Carbamazepine, Olanzapine, Trazodone and Ziprasidone. The system 
achieved a good performance, with a precision of 78.3% and a recall of 69.9%.  
An extension of this system was accomplished by Nikfarjam and Gonzalez 
(2011) [26]. The authors applied association rule mining to extract frequent 
patterns describing opinions about drugs. The rules were generated using the 
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Apriori tool28, an implementation of the Apriori algorithm (Agrawal and Srikant, 
1994 [1]) for association rule mining. The system was evaluated using the same 
corpus created for their previous work (Leaman et al., 2010 [20]), and which has 
been described above. The system achieved a precision of 70.01% and a recall of 
66.32%. The main advantage of this system is that it can be easily adapted for 
other domains and languages. Another important advantage of this approach over 
a dictionary based approach is that the system is able to detect terms not 
included in the dictionary.  
Benton et al., (2011) [5] created a corpus of posts from several online 
forums about breast cancer, which later was used to extract potential adverse 
reactions from the most commonly used drugs to treat this disease: Tamoxifen, 
Anastrozole, Letrozole and Axemestane. The authors collected a lexicon of lay 
medical terms from websites and databases about drugs and adverse events. The 
lexicon was extended with the Consumer Health Vocabulary (CHV)29, a vocabulary 
closer to the lay terms, which patients usually use to describe their medical 
experiences. Then, pairs of terms co-occurring within a window of 20 tokens were 
considered. The Fisher’s exact test (Fisher, 1922 [9]) was used to calculate the 
probability that the two terms co-occurred independently by chance. To evaluate 
the system, the authors focused on the four drugs mentioned above, and then 
collected their adverse effects from their drug labels. Then, precision and recall 
were calculated by comparing the adverse effects from drug labels and the 
adverse effects obtained by the system. The system obtained an average precision 
of 77% and an average recall of 35.1% for all four drugs.  
UDWarning (Wu et al., 2012 [36]) is an ongoing prototype whose main 
goal is to extract adverse drug reactions from Google discussions. A knowledge 
base of drugs and their adverse effects was created by integrating information 
from different resources such as SIDER, DailyMed30, Drugs.com31 and 
MedLinePlus. The authors hypothesized that unknown adverse drug effects would 
have a high volume of discussions over the time. Thus, the systems should 
monitor the number of relevant discussions for each adverse drug effect. 
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However, to the best of our knowledge, the UDWarning’s component devoted to 
the detection of unrecognized adverse drug effects has not been developed yet.  
Bian et al., (2012) [6] developed a system to detect tweets describing 
adverse drug reactions. The systems used a SVM classifier trained on a corpus of 
tweets, which were manually labeled by two experts. MetaMap (Aronson and 
Lang, 2010 [2]) was used to analyze the tweets and to find the UMLS concepts 
present in the tweets. The system produced poor results, mainly because tweets 
are riddled with spelling and grammar mistakes. Moreover, MetaMap is not a 
suitable tool to analyze this type of texts since patients do not usually use medical 
terminology to describe their medical experiences.  
As it was already mentioned, the recognition of drugs in social media texts 
has hardly been tackled and little research has been conducted to extract 
relationships between drugs and their side effects, since most systems were 
focused on a given and fixed set of drugs. Most systems for extracting ADRs follow 
a dictionary-based approach. The main drawback of these systems is that they fail 
to recognize terms which are not included in the dictionary.  In addition, the 
dictionary-based approach is not able to handle the large number of spelling and 
grammar errors in social media texts. Moreover, the detection of ADRs has not 
been attempted for languages other than English. Indeed, automatic information 
extraction from Spanish-language social media in the field of health remains 
largely unexplored. Additionally, to the best of our knowledge, there is no corpus 
annotated with ADRs in social media texts available today. 
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3. The SpanishADR 
corpus 
3.1. Corpus creation and annotation 
One of the main goals of this project was to create the first corpus from 
social media in Spanish annotated with drugs and adverse events, and the first 
step was to obtain a first set of comments from the social media. 
We must remind that, as it is specified in section 2.1, Forumclínic was the 
chosen forum to elaborate the corpus. Forumclínic is an interactive program 
intended for patients to increase their autonomy degree with respect to health, 
using the opportunities given by the newest technologies. 
It provides rigorous, useful, transparent and objective information about 
health, whereas at the same time it boosts active participation of patients and 
associations.  
Its target is to improve citizen's knowledge on health, diseases and their 
causes, as well as the efficiency and safety of the preventive treatments and 
medicines, so that they can get involved with the clinical decisions which attain 
them. 
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Forumclínic users are from all over the world, being significant data the 
fact that 46% of the webpage visits come from Spanish America. In total, the 
million users were reached in 2011, and it maintains a steady increase since it was 
created, in 2007. 
Corpus creation 
The first step in order to obtain the corpus was implementing a web 
crawler which was able to gather all comments in Forumclinic. This was developed 
using Java. The total number of posts obtained from the site was of 84.090, 
distributed by topics in the following way: 
 Esquizofrenia (Schizophrenia): 26.234 [31.20%] 
 Depresión (Depression): 22.938 [27.28%] 
 Cáncer de mama (Breast cancer): 15.675 [18.64%] 
 Trastorno bipolar (Bipolar disorder): 12.573 [14.95%] 
 EPOC (COPD): 1.853 [2.20%] 
 Cardiopatía isquémica (Coronary artery disease): 1.840 [2.19%] 
 VIH – Sida (HIV/AIDS): 1.359 [1.61%] 
 Obesidad (Obesity): 706 [0.84%] 
 Cuídate (Take care): 419 [0.50%] 
 Artrosis y artritis (Osteoarthritis and arthritis): 276 [0.33%] 
 Diabetes (Diabetes): 202 [0.24%] 
 Cáncer de colon y recto (Colon and rectal cancer): 15 [0.02%] 
All these comments were indexed with an alphanumeric code. 
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Figure 8: Forumclínic comments distribution by topic 
A manually annotated corpus was then created consisting of 400 
randomly selected posts (approximately 5% of the total). The quality and 
consistency of the annotation process was ensured through the creation of 
annotation guidelines.  
Annotation Guidelines 
An adverse event is considered to be negative, harmful. It includes any 
negative event that occurs to a patient while taking a drug, both if it is directly 
caused by it or not. For example: a patient takes part in a clinical trial with a drug. 
The responsible of this trial must follow the evolution of the patient, for both 
beneficial and adverse events, and note down all the experiences. This way, if the 
patient has "nausea", this should be annotated. The problem is that in that 
moment it is not possible to assure that "nausea" was caused by the drug or any 
other reason (for instance, the night before the patient could have eaten spoiled 
food). The responsible for the clinic trial would annotate "nausea" as adverse 
event. 
A drug is a substance that is used in the treatment, cure, prevention or 
diagnosis of diseases. Several different types of drugs can be distinguished for the 
annotation, such as generic drugs, brand drugs or group of drugs. 
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DRUG TYPE DESCRIPTION EXAMPLE 
Generic 
drug 
Any chemical agent used in the 
treatment, cure, prevention or diagnosis 
of disease that has been approved for 
human use. It is denominated by a 
generic or chemical name, and not by a 
trade name or brand name. 
Paracetamol 
Brand drug 
Any chemical agent used in the 
treatment, cure, prevention or diagnosis 
of disease that has been approved for 
human use. It is denominated by a trade 
or brand name. 
Abilify 
Family of 
drugs 
A term in the text that describe different 
drugs into groups according to the organ 
or system on which they act or according 
to their chemical, pharmacological or 
therapeutic properties. 
IMAO - 
Inhibidores de la 
Mono Amino 
Oxidasa (MAOI – 
Mono Amine 
Oxidase Inhibitor) 
Table 5: Annotation guidelines referring to drugs 
Taking into account these definitions, the decision was to annotate the 
corpus looking for terms or expressions which fulfilled one of them, organizing the 
tags in "Drug" and "Adverse Event". 
Moreover, anaphoric expressions and orthographic errors regarding both 
sets are also annotated.  
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ANNOTATION DESCRIPTION EXAMPLE 
Anaphoric 
expression 
Presence of an 
element which makes 
reference to 
something previously 
mentioned, in this 
case, a drug or 
adverse event 
...Yo tomaba Alprazolam. Es el 
ansiolítico que más dependencia 
genera... (...I used to take 
Alprazolam. It is the anxiolytic 
which generates a higher 
dependency...) 
Orthographic 
error 
An unintentional error 
of the accepted form 
of spelling a word, in 
this case, a drug or 
adverse event 
Hemorrajia when referring to 
Hemorragia (Hemorrhage) 
Table 6: Annotation guidelines referring to included terms 
Corpus annotation 
The sample of 400 comments was manually labeled with drugs and 
adverse events by two annotators with expertise in Pharmacovigilance. 
Disagreements between the annotators were discussed and reconciled during the 
harmonization process, where a third annotator helped to make the final. All the 
mentions of drugs and adverse events were annotated, even those containing 
spelling or grammatical errors. Nominal anaphoric expressions, which refer to 
previous adverse events or drugs in the comment, were also included in the 
annotation. The annotation tool used in the process was GATE32.  
The process was carried out following the annotation guidelines, which 
were created in an iterative process. The initial annotation guidelines included 
only generic and brand drugs, along with adverse events. This schema was 
discussed and developed by a team with a pharmacist, and two annotators (one 
of them a text mining expert), until the final guidelines were created. 
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Disagreements 
During the aforementioned harmonization process where the third 
annotator helped obtaining a final decision where the two first annotators did not 
coincide, cases like these occurred: 
Orthographic error 
De entre los distintos antiretrovirales, transcriptasa inversa, proteasa, 
integrasa y fusión, qué grupo sería el más potente y cual el menos. 
(Among the different antiretroviral drugs, reverse transcriptase, proteinase, 
integrase and fusion, which group would be the most powerful and which 
one the least) 
Table 7: Example of disagreement resulting in annotation 
This case was consulted with a pharmacist due to the ambiguity. The 
terms in bold refer to a group of drugs (reverse transcriptase inhibitors, 
proteinase inhibitors, integrase inhibitors and fusion inhibitors). Nevertheless, 
they are not written in the correct way due to the absence of the term inhibitor, 
which gives the complete sense to the drug family. Therefore, it is considered an 
incorrect way of writing this family, and it will be annotated as a grammatical 
error of the form of a family drug. 
Family of drug and anaphoric expression 
Como complemento proteico recomendamos el de los laboratorios Vegenat. 
Si compras los complementos del Decathlon, asegúrate que contenga 
proteínas. 
As a protein complement we recommend the Vegenat laboratory's one. If 
you buy Decathlon's complements, make sure they contain proteins. 
Table 8: Example of disagreement resulting in non-annotation 
All annotators agreed that complement proteico was a family of drugs. 
Furthermore, one annotator considered complementos is an anaphoric expression 
of this family, and proteínas as a drug ingredient, and therefore a drug. On the 
other hand, another annotator did not consider complementos or proteínas as 
relevant in the phrase. This is an example of the importance of an odd number of 
annotators, along with a pharmacist or expert in the field to obtain a consistent 
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and high quality annotated corpus. It worth mentioning that complementos del 
Decathlon was not annotated as a drug since it is not a brand-marked drug. 
3.2. Inter-annotation agreement 
To measure the inter-annotator agreement we used the F-measure 
metric. This metric approximates the Kappa coefficient (Cohen, 1960 [8]) when 
the number of true negatives (TN) is very large (Hripcsak and Rothschild, 2005 
[17]). In our case, we can state that the number of TN is very high since TNs are all 
the terms that are not true positives, false positives nor false negatives. The F-
measure was calculated by comparing the two corpora created by the two first 
annotators. The corpus labelled by the first annotator was considered the gold-
standard. As it was expected, drugs exhibit a high IAA (0.89), while adverse events 
point to moderate agreement (0.59). As drugs have specific names and there are a 
limited number of them, it is possible to create a limited and controlled 
vocabulary to gather many of the existing drugs. On the other hand, patients can 
express their adverse events in many different ways due to the variability and 
richness of natural language. 
The annotators found 187 drugs (from which 40 were nominal anaphors 
and 14 spelling errors) and 636 adverse events (from which 48 were nominal 
anaphors and 17 spelling errors). The corpus is available for academic purposes33. 
 DRUGS ADVERSE EVENTS 
Total annotations 187 636 
Nominal anaphors 40 48 
Spelling errors 14 7 
IAA score 0.89 0.59 
Table 9: Summary of the corpus annotation 
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4. System description 
4.1. Architecture 
The architecture of the system is a simple pipeline in GATE, in which we 
embedded two plugins as modules. As we can see in Figure 9: System 
architecture one of them related to Textalytics34 and the other one involving 
gazetteers.  
Textalytics plugin is an entity dictionary which includes the drugs and the 
adverse events that are going to be marked by the system. The dictionaries 
include information from different resources: CIMA for the drugs and MedDRA for 
the adverse events.  
On the other hand, the gazetteers (ANNIE Gazetteers) are lists we 
included in order to improve the performance of the system and to have a more 
complete set of resources. They include information from the WHO ATC system35 
and from the site Vademecum, both to expand the information on drugs and on 
adverse events. 
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Figure 9: System architecture 
GATE 
GATE is an infrastructure for developing and deploying software 
components that process human language. It is open source free software which 
is in active use for any kind of computational task involving human language. 
Thus, it allowed us to create our system with the aforementioned pipeline 
architecture in order to process the posts from the forum. 
As an architecture, GATE suggests that the elements of software systems 
that process natural language and successfully be broken down into several types 
of component, known as resources. In our case, these resources are the dictionary 
and the gazetteers that we mounted on the system, full of biomedical 
terminology oriented to the goal of detecting drugs and adverse events in social 
media. 
When using GATE to develop language processing functionalities for an 
application, the developer uses GATE Developer and GATE Embedded in order to 
create resources, what involves programming and developing language resources. 
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Once the appropriate set of resources is created, they can be embedded in the 
system using GATE Embedded.  
Textalytics 
Daedalus36 is a Spanish company specialized in automatically extracting 
the meaning of all kind of multimedia contents, by applying semantic 
technologies, language processing, voice recognition and data and text analysis. 
Textalytics is a multilingual text analysis engine to extract information 
from any type of texts such as tweets, posts, comments, news, contracts, etc. This 
tool offers a wide variety of functionalities such as text classification, entity 
recognition, concept extraction, relation extraction and sentiment analysis, 
among others. We used a plugin that integrates Textalytics with GATE. In this 
project, we applied entity recognition provided by Textalytics, which follows a 
dictionary-based approach to identify entities in texts. We created a dictionary for 
drugs and adverse events from CIMA and MedDRA. This dictionary was integrated 
into Textalytics.  
4.2. Construction of a dictionary for drugs 
and adverse events 
 Since our goal is to identify drugs and adverse events from user 
comments, the first challenge is to create a dictionary that contains all of the 
drugs and known adverse events.  
4.2.1. Textalytics' dictionary 
Textalytics is one of the analysis resources which will allow the automatic 
annotation of the corpus in our system. The Topic Extraction (v1.1) API is the 
solution for extracting the drugs and adverse events present in the corpus. This 
process is carried out combining a number of natural language processing 
techniques which allow obtaining morphological, syntactic and semantic analyses 
of the corpus in order to identify the aforementioned entities.  
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In order to identify drugs and adverse events, a user dictionary has to be 
created. The dictionary has the following structure: 
' id \ form \ alias{alias1|aliasN} \ pos_tag \ lemma \ checkinfo_tag \ sense \ 
other_info \r \n ' 
Figure 10: Textalytics dictionary structure 
The id is an aleatory number to identify the dictionary's entry, the form is 
the entry, and the alias will be those entities which will be annotated and related 
to the entry. The rest of the information is not important in this section. 
4.2.2. Drug dictionary 
Despite choosing two resources for drugs, only CIMA was used for 
creating the Textalytics drug dictionary. This decision was taken, as for the 
adverse events, due to the organized and relational structure of the resource.  
After studying the files in CIMA, the decision was to create a dictionary in 
which the entries were the generic ingredients, and the aliases were those drugs 
which contained each generic ingredient. With this schema, all drugs and 
ingredients would be available for annotation, and the drug part of the dictionary 
would not be too large. As a matter of fact, this part consisted of 2228 entries 
(one per generic ingredient in CIMA), and a total of 3662 brand names as aliases 
of the first ones, being so when containing the generic ingredient. 
In order to accomplish this objective, the two files to work with were 
Prescripcion.xml and DICCIONARIO_PRINCIPIOS_ACTIVOS.xml. The basic needs 
were obtaining the relations between drugs and their generic ingredients, and the 
brand name for the long and tedious drug names. 
Drugs and generic ingredients relation 
Prescripcion.xml is the main file in the CIMA resource. It is the one which 
covers all information related to all drugs (16418) included in it. This information 
is codified (ATC code appears with “cod_atc”, generic ingredient is shown with 
“cod_principio_activo”, laboratories as “laboratorio_titular” and 
“laboratorio_comercializador”...), and therefore the information has to be 
decoded. 
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For example, for the drug with “National Code” 600000, which receives 
the name of AMOXICILINA/ACIDO CLAVULANICO SALA 500/50 mg POLVO PARA 
SOLUCION INYECTABLE Y PARA PERFUSION EFG, 100 viales, in the 
Prescripcion.xml file, some of the important elements, including the generic 
ingredient, are shown as follows: 
Figure 11: Extract with relevant information from a drug in Prescripcion 
With this structure, other files are needed in order to obtain the desired 
information. The file DICCIONARIO_PRINCIPIOS_ACTIVOS.xml includes the 
information needed to decode and relate the generic ingredients with the drugs 
where they are included: 
Figure 12: Entry of a generic ingredient in DICCIONARIO_PRINCIPIOS_ACTIVOS 
The file DICCIONARIO_PRINCIPIOS_ACTIVOS.xml contains a total of 2228 
generic ingredients registered in CIMA. All the drugs in Prescripcion.xml contain 
one or more of these active ingredients. 
Following the above schema, all drugs in CIMA were related to their 
generic ingredient code. The ingredients will be the entries of the dictionary, and 
the brand names (will now be explained) the aliases. 
Brand name 
The Prescripcion.xml file contains a total of 16418 instances that are all 
brand drugs registered in CIMA. A brand drug is a medication marketed by a 
pharmaceutical company under a trademark name. The aim of the brand name is 
to give a short name for each brand drug. In principle, brand names hold more 
probability to be named or written by the users of social media. 
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The brand drugs saved in the Prescripcion.xml have usually very long 
names containing the brand name as well as information about their dosages, 
their form and administration method (for example, TAMOXIFENO LEPORI 10 mg 
COMPRIMIDOS). It is highly unlikely that these long names are used by patients. 
Therefore, the goal is to obtain their short names (without containing information 
on the dosage, form or route of administration). 
In order to compute the brand name, the starting point is the complete 
brand drug name, which is compiled from the "des_nomco" element (which is 
child of the prescription element), in the Prescripcion.xml. 
In order to do a differentiation between names, it is important to 
introduce the concept of Pharmaceutical Generic Specialty (in Spanish, EFG - 
Especialidad Farmacéutica Genérica).  When a drug is an EFG, its name will be as 
follows: 
Generic Ingredient + Laboratory + Dose/Pharmaceutical Form Info + EFG (+ 
Content Info) 
Figure 13: EFG drug name structure 
An example from CIMA would be: 
PARACETAMOL KABI 10 mg/ml SOLUCION PARA PERFUSION EFG, 10 viales de 
100 ml 
Figure 14: CIMA example of EFG drug 
On the other hand, drugs which are not EFG do not follow a strict pattern. 
Anyway, they can be considered as brand name drugs, where normally the 
generic ingredient does not appear in the name, whereas a commercial name 
does. In general, the structure would be: 
Brand name + Dose/Pharmaceutical Form  Info + Content Info 
Figure 15: Non-generic drug name structure 
An example from CIMA would be: 
VALCYTE 450 mg COMPRIMIDOS RECUBIERTOS CON PELICULA., 60 
comprimidos 
Figure 16: CIMA example of non-generic drug 
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From this moment on, they will be considered as EFG drugs, and brand 
drugs. 
Obtaining the brand name 
First of all, a preprocessing is done to all the drug's long names. In this first step, 
some inconsistencies, redundancy and irrelevant information (such as Content 
Info) from the long names are removed.  
1. Moving on, the next step is looking for a digit in the name. In general, all of 
the drugs in the resource contain a number, which is referring to their 
dosages (‘10’ for the EFG drug and ‘450’ for the brand drug in the examples) 
followed by a dose unit (‘mg/ml’ for EFG, ‘mg’ for brand). If the drug is filtered 
with this constraint, the result would be, for the EFG drugs, the Generic 
Ingredient + Laboratory, and for the brand drugs, directly the commercial 
name, by which it is known. 
2. For each EFG drug, the laboratory name should also be removed in order to 
obtain only the name of its generic ingredient. Therefore, the next step will be 
detecting the laboratory name and removing it in order to achieve the active 
ingredient by itself. It is important to remember that this affects only to the 
EFG drugs.  
With the CIMA documentation it is possible to obtain a list of laboratories 
which will be very useful for this purpose. To do so, in the 
DICCIONARIO_LABORATORIOS.xml, as a child of the laboratorios element, the 
"laboratorio" elements contain the registered name of the laboratories 
registered in CIMA. 
Figure 17: Entry of a laboratory in DICCIONARIO_LABORATORIOS 
The main problem is that the complete registered name of the laboratory is 
not the one mentioned in the long name of the drug. For instance, in the 
previous example, the full name is “PARACETAMOL KABI 10 mg/ml 
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SOLUCION PARA PERFUSION EFG, 10 viales de 100 ml”. Following the rules, 
the laboratory would be “KABI”, but the registered name of this laboratory is 
“FRESENIUS KABI ESPAÑA, S.A.U.”. Thus, in order to obtain a Laboratory List 
with the laboratory names which are mentioned in the drug names, a 
filtering process has to be done to the long laboratory names (similar to the 
one done to the long brand names to obtain the short brand names). 
Based on the observation of the list of long laboratory names, a list of stop 
words was compiled, including terms which can be removed from the 
registered laboratory names in order to obtain their equivalents as they are 
found in the drug name. Some examples of the most common stop words 
and their meaning (acronyms and foreign terms) are shown in the table 
below.  
STOP WORD FOR 
LABORATORY 
MEANING 
LABORATORIO 
 
FARMACÉUTICA 
 
SPAIN 
 
ESPAÑA 
 
UK 
 
DEUTSCHLAND 
 
ARZNEIMITTEL Drug in German 
LIMITED S.L. in English 
LTD LIMITED abbreviation 
S.A. [acronym] Sociedad Anónima 
S.L. [acronym] Sociedad Limitada 
S.R.L. [acronym] Sociedad de Responsabilidad Limitada 
GMBH 
[acronym] Gesellschaft Mit Beschränkter Haftung (S.R.L. in 
German) 
AG [acronym] Aktiengesellschaft (S.A. in German) 
A/S [acronym] Aktieselskab (S.A. in Danish) 
AB [acronym] Aktiebolag (S.L. in Swedish) 
B.V. [acronym] Besloten Vennootschap (S.R.L. in Dutch) 
Table 10: Most frequent stop words for laboratories 
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3. Unfortunately, not all drug names follow the previous patterns (EFG or 
brand).  An example would be: 
AGUA BIDESTILADA AMPOLLAS, 1 ampolla de 10 ml 
Figure 18: CIMA example of a drug name with no pattern 
The only identifiable part of the name is the Content Info. Apart from that, 
there is not a clear generic ingredient (the term AGUA appears in four generic 
ingredients, but not by itself or accompanied by BIDESTILADA), laboratory 
name or detectable brand.  
These cases will be treated in a particular way, filtered with a list of stop 
words. The list will be compiled with words from different lists in CIMA, and a 
set of synonyms and related words.  
 The first words are found in CIMA's file 
DICCIONARIO_UNIDAD_ADMINISTRACION, 
DICCIONARIO_FORMA_FARMACEUTICA [.xml]. In the first one, under the 
elements "unidadadministracion", child of unidadesadministracion, there 
are terms related to drugs administration, such as COMPRIMIDOS, 
JERINGA or PASTILLAS. Moreover, in the second one, in 
"formafarmaceutica" tag, child of the also called formafarmaceutica 
element, terms describing pharmaceutical forms are found, as for 
example, SOLUCIÓN ORAL, POLVO PARA INHALACIÓN or POMADA NASAL. 
Within these terms, stop words are retrieved (SOLUCIÓN, POLVO, 
POMADA...). They will be a first approach (around 70 words) to the final 
list of stop words which will be used to filter the drugs.  
For instance, regarding the example above, the stop word AMPOLLAS is 
detected, and the brand name for the drug will result as AGUA 
BIDESTILADA. 
 Despite the use of this first list helped cleaning the names, there were still 
some words similar to the ones obtained from the CIMA files, but which 
did not appear in these. This leads to the second kind of words. For 
example, the term PASTILLA (i.e. MUCOSAN 15 mg PASTILLAS DE GOMA, 
40 pastillas) was part of the Administration Unit List (compiled from 
DICCIONARIO_UNIDAD_ADMINISTRACION.xml), and therefore was 
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defined as a stop word; but on the other hand, a similar word like 
CARAMELO (i.e. CHICLIDA CARAMELO, 6 pastillas) was not in the CIMA 
document, thus it does not appear as a stop word. They both refer to 
administration units of a drug, so they both should be on the list. These 
words were detected by observation (going over the resulting drug names 
and spotting them) and added to the stop word list. More examples of 
these words would be TABLETA, REPETABS, COLUTORIO or FILM, all of 
them pharmaceutical forms but which did not appear in CIMA. 
 One step forward was including in the list of stop words those which did 
not contribute enough in the differentiation of two drugs. For instance, 
ADOLONTA 100 mg/ml GOTAS ORALES EN SOLUCION, 1 frasco de 30 ml is 
the long name for a drug with National Code 665364. Moreover, the 
fabrication and commercialization laboratories are both GRÜNENTHAL 
PHARMA, S.A., its ATC code is N02AX02 - Tramadol, and it consists of one 
generic ingredient, TRAMADOL HIDROCLORURO. 
On the other hand, there is another drug, ADOLONTA RETARD 200 mg 
COMPRIMIDOS DE LIBERACION PROLONGADA, 20 comprimidos whose 
National Code is 665588. In this case, the laboratory is again 
GRÜNENTHAL PHARMA, S.A. both for fabrication and commercialization, 
the ATC code is the same, N02AX02 - Tramadol, and also the generic 
ingredient, TRAMADOL HIDROCLORURO. 
This is something quite common among drugs. Their composition can be 
varied by just some different excipients, which are generally inactive 
substances which are mixed with the generic ingredients (which in these 
cases would be the same) in order to give consistency and 
pharmacological characteristics to a drug. 
In the previous example it was appreciated how a very similar drug is 
differentiated in its name by a possible key word (or stop word) such as 
“RETARD”. Due to the previous explanation, these two drugs could share 
the same brand name (ADOLONTA). 
 As it happens with this example, this is something quite common along 
the drugs in CIMA, and therefore there is a great number of stop words of 
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this kind. Examples of them would be NIÑOS, ADULTOS, INFANTIL, 
INFANT, JUNIOR... 
 Still, there are some words which do not add any value to the brand 
name, and therefore should not be part of it. These are, for 
example, INICIO, CENTRAL, PERIFERICO or CHOQUE among others 
Summing up, the total number of words in the list of stop words was of 235, 
some of them shown in the following table: 
STOP 
WORD 
EXAMPLE IN CIMA 
 
BACTROBAN 20 mg/g POMADA 
NASAL BACTROBAN NASAL, POMADA 
 
ABRASONE CREMA 
RECTAL ABRASONE RECTAL 
 
ACEOTO SOLUCION 
PLUS ACEOTO PLUS 3/0,25 mg/ml GOTAS ÓTICAS EN SOLUCIÓN 
 
APIRETAL 100 mg/ml SOLUCION ORAL 
NIÑOS APIRETAL NIÑOS 250mg SUPOSITORIOS 
 
FEBRECTAL 650 mg COMPRIMIDOS 
ADULTOS FEBRECTAL ADULTOS 600 mg SUPOSITORIOS 
 
FLUMIL 200 mg GRANULADO PARA SOLUCION ORAL 
INFANTIL FLUMIL INFANTIL 100 mg GRANULADO PARA SOLUCION ORAL 
 
AMINOVEN 10% SOLUCION PARA PERFUSION 
INFANT AMINOVEN INFANT 10% SOLUCION PARA PERFUSION 
 
FRENADOL COMPRIMIDOS EFERVESCENTES 
JUNIOR FRENADOL JUNIOR 
 
CLARITROMICINA TEVA 250 mg COMPRIMIDOS RECUBIERTOS CON 
PELICULA EFG 
UNIDIA 
CLARITROMICINA UNIDIA TEVA 500 MG COMPRIMIDOS DE 
LIBERACION PROLONGADA EFG 
 
RISEDRONATO TEVA 75 mg COMPRIMIDOS RECUBIERTOS CON 
PELICULA EFG 
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SEMANAL 
RISEDRONATO SEMANAL SANDOZ 35 mg COMPRIMIDOS 
RECUBIERTOS CON PELICULA EFG 
DIARIO 
DECAPEPTYL DIARIO 0,1 mg, POLVO Y DISOLVENTE PARA 
SOLUCION INYECTABLE 
MENSUAL 
DECAPEPTYL MENSUAL 3,75 mg, POLVO Y DISOLVENTE PARA 
SUSPENSION INYECTABLE 
TRIMESTRAL 
DECAPEPTYL TRIMESTRAL 11,25 mg POLVO Y DISOLVENTE PARA 
SUSPENSION INYECTABLE 
SEMESTRAL 
DECAPEPTYL SEMESTRAL 22,5 mg POLVO Y DISOLVENTE PARA 
SUSPENSION INYECTABLE 
 
ADOLONTA 100 mg/ml GOTAS ORALES EN SOLUCION 
RETARD 
ADOLONTA RETARD 200 mg COMPRIMIDOS DE LIBERACION 
PROLONGADA 
 
AERO-RED 120 mg COMPRIMIDOS MASTICABLES 
FORTE AERO-RED FORTE 240 MG CAPSULAS BLANDAS 
 
BEKUNIS TISANA 
COMPLEX BEKUNIS COMPLEX COMPRIMIDOS RECUBIERTOS 
INSTANT BEKUNIS INSTANT, POLVO PARA SOLUCIÓN ORAL 
 
DESLORATADINA COMBIX 5 mg COMPRIMIDOS RECUBIERTOS CON 
PELÍCULA EFG 
FLAS 
DESLORATADINA FLAS COMBIX 5 mg COMPRIMIDOS 
BUCODISPERSABLES EFG 
 
VOLTAREN  50 mg COMPRIMIDOS GASTRORRESISTENTES 
EMULGEL VOLTAREN EMULGEL 1% 
GEL DALGEN GEL 
SPRAY DALGEN SPRAY SOLUCION 
Table 11: Most frequent stop words for drugs
Figure 19: Summary of brand name creation 
After the review of the CIMA resource and the creation of the drug part of 
the dictionary, the final numbers obtained are the following: 
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RESOURCE TOTAL 
Generic drugs from CIMA 2,228 
Brand drugs from CIMA 3,662 
Total drugs from CIMA: 5,890 
Table 12: Number of drugs in the dictionary 
4.2.3. Adverse Event dictionary 
The two selected resources regarding the adverse events were MedDRA 
and Vademecum. Due to the structure of the first one, it was chosen to be the 
leading one in the dictionary. 
The two lower levels from MedDRA (PT - Preferred Terms and LLT - 
Lowest Level Terms) were extracted from the resource. Level 5 (last level, PPT) is 
composed of specific adverse events (i.e. Dolor de cabeza - Headache), whereas in 
level 4 (PT) more general adverse events are found (i.e. Cefalea - Cephalgia). Thus, 
a relation between general and specific adverse events can be depicted from 
layers 4 and 5 in MedDRA, and therefore this relation can be used for entries of 
the dictionary and its aliases.  
There are a total of 72.072 Lowest Level Terms, and 20.307 Preferred 
Terms. These last ones are included in the first ones (thus, every PT has at least 
one alias - itself). Therefore, with the implementation decision, the dictionary has 
20307 entries (PT) for adverse events, and a total of 72072 aliases (LLT). 
For example, dolor hepático (Liver pain), with MedDRA code 10019705, is 
a Preferred Term from the level 4 in MedDRA. In the dictionary it will be a new 
entry for an adverse event, with ID equal to the code in MedDRA. In the level 5, as 
Lower Level Terms associated to Dolor hepático, there is a list of terms, such as 
itself, dolor hepático (code 10019705), dolor de hígado (code 10024703) and dolor 
hepatobiliar (code 10057960). These terms will be the aliases.  
As a matter of fact, after the creation of the adverse event part of the 
dictionary, the final numbers in our resource were: 
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RESOURCE TOTAL 
Adverse events from MedDRA 72,072 
of which as entries 20,307 
of which as aliases 72,072 
Total adverse events: 72,072 
Table 13: Number of adverse events in the dictionary 
4.3. Construction of gazetteers 
By analyzing the information from these resources, we found that none of 
them contained all of the drugs and adverse events. Patients usually use lay terms 
to describe their symptoms and their treatments. Unfortunately, many of these 
lay terms are not included in the above mentioned resources. Therefore, we 
decided to integrate additional information from other resources devoted to 
patients to build a more complete and comprehensive dictionary. There are 
several online websites that provide information to patients on drugs and their 
side effects in Spanish language. For example, Vademecum contains information 
about drugs and their side effects. This website allows users to browse by generic 
or drug name, providing an information leaflet for each drug in a HTML page. 
Since these leaflets are unstructured, the extraction of drugs and their adverse 
effects is a challenging task. While drug names are often located in specific fields 
(such as title), their adverse events are usually descriptions of harmful reactions in 
natural language. We developed a web crawler to browse and download pages 
related to drugs from Vademecum since this website provided an easier access to 
its drug pages than others, such as MedLinePlus. 
With the Textalytics dictionary complete, the main resources were 
integrated and could be annotated by the system by means of the Textalytics 
Topic Extraction API. 
Nevertheless, there were other resources to integrate, plus extra 
information which could be important in order to enlarge the scope for 
annotation. In order to achieve this goal, different gazetteers were implemented. 
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A gazetteer can be defined as a set of lists which contains entities (in this 
case, drugs, generic ingredients, families of drugs and adverse events), which will 
be annotated by GATE if there are occurrences in a text. 
Drug families - WHO ATC system gazetteer 
Users may refer to a specific drug by its brand name (Espidifén), its active 
ingredient (Ibuprofeno) or in a more general way, by its family name 
(antiinflamatorios). The first two options are included in the drug part of the 
dictionary, whereas the third possibility was not part of the system.  
The ATC code (Anatomical Therapeutic Chemical Classification System) is a 
pharmaceutical coding system which is organized by therapeutic groups, and is 
controlled by the WHO Collaborating Center for Drug Statistics Methodology 
(WHOCC).  
The system is structured in five levels, being the last one the generic 
ingredients, and the fourth one the chemical/therapeutic/pharmacological 
subgroups. By obtaining the subgroups from all the 14 anatomic groups (first 
level), and organizing them in families of drugs, a gazetteer with 466 families was 
created. 
Drugs and Adverse events – Vademecum gazetteer 
The main limitation of CIMA is that it only provides information about 
drugs authorized in Spain. That is, CIMA does not contain information about drugs 
approved only in Latin America. 
Nevertheless, a total of 4238 drugs were obtained from Vademecum, and 
then compared with the ones in CIMA in order to filter the ones which were 
included in both resources, and to create a gazetteer with the ones from 
Vademecum which were not part of CIMA. A gazetteer with 1237 drugs was 
compiled with these drugs. 
On the other hand, the main limitation of MedDRA is that that its contents 
are not in lay language, and therefore there are not always found in a user’s post. 
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Thus, the 2793 adverse events which were gathered with the web crawler 
from Vademecum, which were more patient-oriented, were also included in the 
gazetteer. 
After the extraction and implementation of all the drugs and adverse 
events which appeared in the resources that we studied, the final numbers in 
terms of entities were: 
RESOURCE TOTAL 
Generic drugs from CIMA 2,228 
Brand drugs from CIMA 3,662 
Drug group names from the ATC system 466 
Drug names (which are not in CIMA) from Vademecum 1,237 
Total Drugs: 7,593 
Table 14: Number of drugs in total 
RESOURCE TOTAL 
Adverse events from MedDRA 72,072 
Adverse events from Vademecum (which are not in MedDRA) 2,793 
Total adverse events: 74,865 
Table 15: Number of adverse events in total
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5. Evaluation 
5.1. Metrics for information extraction 
In order to be able to evaluate the obtained results it is critical to choose 
clear, reproducible and easily understood evaluation metrics. The first thing 
before introducing the metrics is to define a structure known as confusion matrix 
or contingency table. This is divided into four categories:  
 True Positives (TP): Examples correctly labeled as positives 
 False Positives (FN): Negative examples incorrectly labeled as positives 
 True Negatives (TN): Negative examples correctly labeled as positives 
 False Negatives (FN): Positive examples incorrectly labeled as negatives 
 Predicted Positive Predicted Negative 
Actual Positive TP FN 
Actual Negative FP TN 
Table 16: Confusion matrix 
Table 16 shows the structure of the confusion matrix, which is a table in 
which each column represents the number of predictions of each class, whereas 
the rows represent the instances of the real class. Therefore, each element shows 
the number of examples for which the actual class is the row and the predicted 
class is the column. 
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True positives and false negatives are mutually related, as it happens with 
false positives and true negatives. We will define N+ as the total number of 
positive examples, whereas N- will be the total number of negative examples. 
Therefore, it is understandable that TP and FN are complementary labels for N+ 
and the same way TN and FP are for N-. It is important to mention that TP and FP 
are the only two of all the numbers TP, FP, TN, and FN which are independent. 
            (5.1) 
                         (5.2) 
In the following list we will define several metrics based on the confusion 
matrix: 
 True Positive Rate (TPR): Measures the fraction of positive examples 
which is correctly labeled. TPR is also referred to as sensitivity or recall. 
This score is typically used to evaluate the performance of medical tests. 
                         
  
     
  
  
  
  (5.3) 
 False Positive Rate (FPR): Measures the fraction of negative examples that 
is wrongly classified as positive. 
     
  
     
  
  
  
    (5.4) 
 True Negative Rate (TNR): Measures the fraction of negative examples 
that is correctly classified as negative. TNR is also referred to as specificity. 
In medical applications, FPR is replaces with TNR. 
                  
  
     
  
  
  
  (5.5) 
 False Negative Rate (FNR): Measures the fraction of positive examples 
that is wrongly classified as negative. 
     
  
     
  
  
  
    (5.6) 
From these equations we make it clear that: 
             (5.7) 
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             (5.8) 
As we are dealing with an information extraction system, whose performance 
is normally evaluated with the recall (equation 5.3) and precision values, we must 
introduce the definition of the last one: 
 Precision: The proportion of detected examples that are actually positive 
examples 
           
  
     
    (5.9) 
An ideal information extracting system is the one where FN = 0 and FP = 0. 
Precision and recall measures stand in opposition to one another. When precision 
increases, recall usually decreases, and vice versa.  
 F-measure: Defined by the harmonic (weighted) average between 
precision and recall, where the parameter beta indicates a relative weight 
of precision with respect to the recall. When β = 1, the balanced F-score 
(F1) is such that recall and precision are evenly weighted. Meanwhile, 
when β = 2 (F2), an overall performance is achieved, in this case, giving 
more importance to the precision (double the recall). 
 ( )   
(     )  
     
    (5.10) 
5.2. Results 
We evaluated the system in two steps on the corpus annotated with drugs 
and adverse events. The first time we measured the results it was when only the 
dictionary was created, but no extra information was induced by the gazetteers. 
The second evaluation took place with the complete system as it is known 
throughout this document. 
First evaluation. Only dictionary with drugs and adverse events 
PRECISION RECALL F-MEASURE 
Drugs 0.69 0.47 0.56 
Adverse Events 0.83 0.37 0.51 
Table 17: First evaluation results 
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The results of this first evaluation show a precision of 69% for drugs and 
83% for adverse events, and a recall of 47% for drugs and 37% for adverse events. 
This concluded in an F-score of 56% for drugs and 51% for adverse events. 
The results regarding drugs were lower than expected, and that is what 
made us think about possible improvements, which came in form of gazetteers. 
On the one hand, we noticed that the families of drugs were a very common issue 
that it was easily solved with the ATC code information. Moreover, the integration 
of a resource like Vademecum gave us over 1.000 extra drugs. On the other hand, 
the low results provided by the adverse events were more expected. The lay 
language used in social media will make this result very difficult to improve. 
Anyway, with the integration of Vademecum in the gazetteer, more adverse 
events were included in the system’s resources. 
Second evaluation. Dictionary and gazetteers (complete 
system) 
PRECISION RECALL F-MEASURE 
Drugs 0.88 0.80 0.84 
Adverse Events 0.85 0.56 0.67 
Table 18: Second evaluation results 
The second and final evaluation, after integrating the gazetteers into the 
system showed a high improvement. In this case we can see a precision of 88% for 
drugs and 85% for adverse events, and a recall of 80% for drugs and 56% for 
adverse events. This concluded in an F-score of 84% for drugs and 67% for adverse 
events. 
We could see, as we were expecting, that the integration of the family of 
drugs gazetteer improved considerably the results for the drugs. Furthermore, the 
improvement in the adverse events part of the dictionary in addition to the extra 
events obtained from Vademecum, which were written in a more patient-
oriented way, was clearly visible in the increase of the adverse events results. 
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Evaluation comparison 
 
Figure 20: Comparison between first and second evaluation 
We can see a very important increase in all the results regarding drugs. As 
a matter of fact, in the F-score there is an uplift of 31 p.p., what means an 
improvement of over 55% with respect to the first evaluation. What is more, the 
biggest upgrade is found in the drug’s recall, with an uplift of 33 p.p.  
The improvement in terms of adverse reactions is not as high due to the 
fact that the results for precision in the first evaluation were already very high. 
Anyway, the uplift of 19 p.p. in terms of recall increases the F-score in 16 p.p. up 
to a satisfactory 67%. 
5.3. Error analysis 
We performed an analysis to determine the main sources of error in the 
system. A sample of 50 user comments were randomly selected and analyzed.  
Adverse events error analysis 
False Negatives 
Regarding the detection of adverse events, the main source of false 
negatives was the use of colloquial and lay expressions to describe an adverse 
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event. Expression like “me deja ko” (it makes me KO), “mi vida no va a ningún 
lado” (my life is going nowhere), or “me cuesta más levantarme” (it's harder for 
me to wake up) were used by patients in order to express their adverse events. 
These phrases are not included in our resources. The idiomatic expressions along 
with the desire of emphasizing statements make it very difficult to create a 
suitable lexicon.  
The second highest cause of false negatives for adverse events was due to 
the different lexical variations of the same adverse event. For instance, 
“depresión” (depression) is a term included in our dictionary, but its lexical 
variations, like for example “deprimido” (depressed - masculine), “deprimida” 
(depressed - feminine), “me deprimo” (I get depressed), “depresivo” (depressive), 
“deprimente” (depressing) are not, and therefore are not detected by our system.  
The third largest cause is spelling mistakes. We can see an example with 
“hemorrajia”, which is an incorrect way of writing “hemorragia” (hemorrhage). 
Many users have great difficulty in spelling unusual and complex technical terms 
like the ones appearing in medicine.  
The last important error source was the use of abbreviations (“depre” is 
an abbreviation for “depression”), which also produces false negatives. 
False Positives 
False positives for adverse events were mainly due to the inclusion of 
MedDRA terms referring to procedures (such as therapeutic, preventive or 
laboratory procedures) and tests in our dictionary. MedDRA includes terms for 
diseases, signs, abnormalities, procedures and tests.  We should have not 
included those terms referring to procedures and tests since they do not 
represent adverse events. In this case we are talking of words such as 
“prevención” (prevention), “análisis” (analysis) or “cirugía” (surgery). 
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Summary 
FALSE NEGATIVES (FN) 
Cause Example 
Lay expressions 
Me deja KO (it makes me KO) 
Mi vida no va a ningún lado (my life is going nowhere) 
Me cuesta más levantarme  (it's harder for me to wake up) 
Lexical variability 
Depresión  (depression) 
Deprimido (depressed - masculine) 
Deprimida (depressed - feminine) 
Me deprimo (I get depressed) 
Depresivo (depressive) 
Deprimente (depressing) 
Spelling mistakes Hemorrajia [hemorragia] (hemorrhage) 
Abbreviations Depre [depresión] (depression) 
Table 19: False negatives in the AdverseEvent recognition task 
FALSE POSITIVES (FP) 
Cause Example 
Non-adverse events terminology 
Prevención (prevention) 
Análisis (analysis) 
Cirugía (cirugía) 
Table 20: False positives in the AdverseEvent recognition task 
Drugs error analysis 
False Negatives 
The main source of false negatives for drugs seems to be that users often 
misspelled drug names. Some generic and brand drugs have complex names for 
patients. Some examples of misspelled drugs are Avilify (Abilify) or Rivotril 
(Ribotril).  
Another important cause of false negatives was due to the fact that our 
dictionary does not include drugs approved in other countries than Spain (for 
example, Clorimipramina, Ureadin or Paxil). However, ForumClinic has a large 
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number of users in Latin America. It is possible that these users have posted 
comments about some drugs that have only been approved in their countries.  
The third largest source of errors was the abbreviations for drug families. 
For instance, benzodiacepinas (benzodiazepine) is commonly used as benzos, 
which is not included in our dictionary.  
An interesting source of errors to point out is the use of acronyms 
referring to a combination of two or more drugs. For instance, FEC is a 
combination of Fluorouracil, Epirubicin and Cyclophosphamide, three 
chemotherapy drugs used to treat breast cancer. This combination of drugs is not 
registered in the resources (CIMA and Vademecum) used to create our dictionary. 
False Positives 
Most false positives for drugs were due to a lack of ambiguity resolution. 
Some drug names are common Spanish words such as “Allí” (a slimming drug) or 
“Puntual” (a laxative). These terms are ambiguous and resolve to multiple senses, 
depending on the context in which they are used.  
Similarly, some drug names such as “alcohol” or “oxygen” can take a 
meaning different than the one of pharmaceutical substance.  
Another important cause of false positives is due to the use of drug family 
names as adjectives that specify an effect. This is the case of sedante (sedative) or 
antidepresivo (antidepressant), which can refer to a family of drugs, but also to 
the definition of an effect or disorder caused by a drug (sedative effects). 
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Summary 
FALSE NEGATIVES (FN) 
Cause Example 
Drug name misspelling 
Avilify [Abilify] 
Rivotril [Ribotril] 
Drugs outside Spain 
Clorimipramina 
Ureadin 
Paxil 
Drug famililes abbreviations 
Benzos (Benzodiacepinas) 
[Benzodiazepine] 
Acronyms for drug combinations 
FEC: Fluorouracil, Epirubicin and 
Cyclophosphamide 
Table 21: False negatives in the DrugName recognition task 
FALSE POSITIVES (FP) 
Cause Example 
No ambiguity resolution 
Allí (There) [Sliming drug] 
Puntual (Punctual) [Laxative] 
Drug family as adjective 
Sedante (Sedative) 
Antidepresivo (Antidepressant) 
[La pastilla que me mandó me ha causado un 
efecto sedante] 
Table 22: False positives in the DrugName recognition task
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6. Budget 
6.1. Project description 
Author: Ricardo Revert Arenaz 
Department: Informatics 
Title: Detecting drugs and adverse events from Spanish health social media 
streams 
Duration: Started September 9th 2013 and ended January 24th 2014. Totally, 560 
hours were needed for the realization of this project. 
6.2. Costs calculation 
Wages of personnel 
Project carried out by a single person, which took responsibility of all the 
tasks. In the next table the breakdown of personnel is shown: 
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STAGE COST/HOUR TOTAL HOURS TOTAL COST 
Analysis 
€ 90,00 
75 € 6.750,00 
Design 60 € 5.400,00 
Coding 150 € 13.500,00 
Tests 110 € 9.900,00 
Experiments 75 € 6.750,00 
Documentation 90 € 8.100,00 
TOTAL 560 € 50.400,00 
Table 23: Wages of personnel 
Equipment costs 
For the realization of this project, a laptop was used during the entire 
duration, as well as a desktop computer was used for tests and experiments for 
one month. 
CONCEPT UNIT TOTAL COST 
Laptop 1 € 785,00 
Testing desktop computer 1 € 580,00 
TOTAL € 1.365,00 
Table 24: Equipment costs 
Software costs 
The cost of the operating system of both computers is included in the 
table above as it was included with the hardware. Furthermore, GATE is a free 
open source software so it has no cost, and Textalytics Professional API has a cost 
of 149 €/month (with I.V.A). Regarding the documentation stage, Microsoft Office 
2010 was included with the operating system.so it is included in the table above. 
CONCEPT UNIT TOTAL COST 
Operating System 2 € 0,00 
GATE 1 € 0,00 
Textalytics Professional API 1 € 123,00 
TOTAL € 123,00 
Table 25: Software costs 
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Expendable and other costs 
The cost of material such as paper, printer ink and other expenses which 
have not been considered in the aforementioned concepts are: 
CONCEPT TOTAL COST 
Paper € 30,00 
Printer ink € 20,00 
Other expenses € 90,00 
TOTAL € 140,00 
Table 26: Expendable and other costs 
Indirect costs 
In order to do an approximation of the indirect costs, we are going to 
suppose an indirect cost rate of 20%.  
6.3. Budget 
Next, the breakdown of the total budget of the project based on all the 
costs above explained: 
CONCEPT TOTAL COST 
Wages of personnel € 50.400,00 
Equipment costs € 1.365,00 
Software costs € 123,00 
Expendable and other costs € 140,00 
Indirect costs € 10.405,60 
Value-add tax (I.V.A - Impuesto sobre el Valor Añadido – Tipo 
general del 21%) 
€ 13.111,06 
TOTAL € 75.544,66 
Table 27: Total budget 
Therefore, the total cost of the budget is of SEVENTY FIVE THOUSAND 
FIVE HUNDRED FOURTY FOUR EUROS AND SIXTY SIX CENTS (€ 75.544,66), 
including the value-add tax corresponding to the general type of 21%
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7. Conclusions and 
future work 
7.1. Accomplished objectives 
In this research, we created the first Spanish corpus of health user 
comments annotated with drugs and adverse events. This corpus is now available 
for research. In this work, we focused only on detecting the mentions of drugs 
and adverse events, and not on the relationships among them. 
Furthermore, we also implemented the first system working in Spanish for 
the detection of drugs and adverse events. Nevertheless, to the best of our 
knowledge there are now other systems working in Spanish detecting drugs and 
adverse events, but not oriented to health social media streams. 
Moreover, there is pipeline for entities detection now available online37, 
where the system can be tested. 
The creation of a gold-standard corpus with comments from health 
related social media is of a high importance regarding the future development 
and improvements in information extraction techniques in Spanish. 
                                                          
37
 http://163.117.129.57:8090/gate/ 
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In terms of performance, the developed system turned out to have very 
successful results. The F-score for the drugs was of 87% and for the adverse 
events of 67%, leaving an unweight average of 77%. The fact that the results for 
drugs are higher than the ones for adverse events has a straight forward 
explanation. Drugs are a finite source, where medicines have a name and a 
reduced way of referring to them. This makes it possible to create a more precise 
dictionary regarding drug names and families, and leaving as a main source of 
error misspellings and abbreviations. On the other hand, the ways to refer to 
adverse events are uncountable. There are as many ways as patients expressing 
them on social media. The lay language is the most common when dealing with 
forums, and it is almost impossible to obtain a dictionary which includes all of 
them. Therefore, we will later take a look at other ways of improving the system. 
Another important issue to point out is the outstanding improvement 
committed over the system after the first evaluation. With still quite good results 
in precision (69% for drugs and 83% for adverse events), the poor performance in 
recall (47% for drugs and 37% for adverse events) made us reconsider the 
direction the system was taking and found the answer to our problems. This was 
the creation of the gazetteers, which would give us more lay language, and a 
reduced cleanup of the dictionary, which made the system obtain much better 
results. In fact, as it was said in Chapter 5, the improvement in the drug’s F-score 
was of 31 p.p. (56% vs. 87%), whereas in the adverse event’s one was of 16 p.p. 
(51% vs. 67%), concluding in an unweight average improvement of 23.5 p.p. 
(53.5% vs. 77%). 
Despite the good results, the system can still reach a better performance. 
The main sources of errors which can be found when evaluating a health social 
media based corpus are the lay expressions and spelling and grammatical 
mistakes, as well as the use of abbreviations and the lexical variations that words 
offer. With the purpose of moving on and improving the system, we will comment 
the future guidelines to follow. 
It is interesting to comment that with the content of this study, a research 
article (Segura-Bedmar et al., 2014 [28]) was introduces in the 5th International 
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Workshop on Health Text Mining and Information Analysis (Louhi38), which took 
place in the 14th Conference of the European chapter of the Association for 
Computational Linguistics (EACL39), in Gothenburg, Sweden, were it was selected 
and published in the proceedings40 for Louhi 2014. 
7.2. Future work 
To begin, the main objective would be to improve on the spots where the 
system is obtaining worse performance. Therefore, taking a look at the main 
sources of error, we could obtain the first future guidelines. 
The first and most obvious step would be integrating more resources in 
the system. To date, we have CIMA for drugs and MedDRA for adverse events, 
with support of gazetteers compiled from resources such as Vademecum or the 
WHO ATC code. The more integrated resources, the better the performance is 
expected to be. 
As for the main source of error in this kind of text, the lay language and 
colloquial expressions, the main improvement can come from the creation of a 
lexicon formed by this kind of vocabulary and expressions. The larger the lexicon 
with lay expressions, the higher the improvement in the results will be. 
Another improvement which could show very good results would be the 
introduction of nominalization for lexical variations. In this way, and following the 
example in Chapter 5, by including the word depresión in the dictionary, the 
system would detect as many lexical variations as a patient can express. Thus, 
terms such as deprimido (depressed), me deprimo (I get depressed), depresivo 
(depressive) or deprimente (depressing) would no longer imply false negatives.  
Along with the lexical variations and the lay expressions, we have a very 
important source of error like the spelling mistakes. In order to suppress this 
issue, the introduction of advanced matching methods would suppose a 
significant improvement in the results. Computing distances between two words 
                                                          
38
 http://dsv.su.se/en/research/research-areas/language/description/louhi-2014-1.154970 
39
 http://eacl2014.org/ 
40
 http://www.aclweb.org/anthology/W/W14/#1100 
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(the correct one and the one with the spelling mistake), this problem can come to 
an end. 
Moreover, in future work, we plan to extend the system to detect the 
relations between drugs and their side effects. Furthermore, we would like to 
identify their indications and beneficial effects. 
Other possible guidelines to future work could be developing a 
multilingual system which is capable of being applied to different languages. The 
positive starting point would be the fact that MedDRA’s contents exist in different 
languages, which makes it possible to relate expressions by a code that they 
share. Of course, other resources from different languages should be integrated, 
both for drugs and adverse events. 
Finally, a differentiated guideline for the future would be the 
development of a corpus and a system for other kind of documents in Spanish 
rather than social media, as for example, drug packet inserts. Despite seeming 
unrelated to this project, the majority of the resources could be shared, and the 
discovery of different ones could contribute in an improvement for both systems. 
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